Intel Technology: Based on the actual construction situation of the fund-raising project and the company's development needs, the company plans to adjust the investment amount and “supplementary working capital” amount of the “annual output 170,000 sets of high-efficiency heat exchanger production base construction project” and the “R&D center construction project” without changes; at the same time, change the “annual output 170,000 sets of high-efficiency heat exchanger production base construction project” to invest in the new project “Production Base Construction Project with an annual output of 1,000 sets of evaporative condenser complete equipment”. Renhe Pharmaceutical: The subsidiary Jiangxi Shanliang Pharmaceutical recently received a drug registration certificate for sodium hyaluronate eye drops approved and issued by the State Drug Administration, indicating that the company is qualified to produce and sell this drug in the domestic market. Hyaluronic acid eye drops are used for dry eyes to relieve dry eye symptoms. Currently, several sodium hyaluronate eye drops are on the market in China.